PRODUCT DESCRIPTION:
NATtrol™ CT.NG Panel (NATCT.NGP-C) is formulated with purified, intact bacterial particles that have been chemically modified to render them non-infectious and refrigerator stable*. NATCT.NGP-C panel contains 17 x 1.2 mL vials each containing the bacterial NATtrol™ targets listed in the Expected Results. These controls are  supplied in a purified protein matrix that mimics the composition of a true clinical specimen. *NATtrol™ Patents Pending

INTENDED USE:
- NATtrol™ CT.NG Panel is designed to evaluate the performance of nucleic acid tests for determination of the presence bacterial DNA. NATCT.NGP-C can also be used for verification of clinical assays, development of diagnostic tests and training of laboratory personnel.
- NATCT.NGP-C contains intact organisms and should be run in a manner identical to that used
for clinical specimens.

ETIOLOGIC STATUS/BIOHAZARD TESTING:
- NATtrol™ inactivation was carried out on each member in the panel. The inactivation was verified by the absence of bacterial growth in a validated growth protocol.
- The purified protein matrix was manufactured from materials that were screened and found to be negative for HIV 1&2 Ab, HBsAg, HTLV I&II Ab, HCV Ab, HIV RNA, HBV DNA and HCV RNA using FDA cleared kits at the single donor level.

Catalog #: NATCT.NGP-C

For more information download PDF file

PRODUCT DESCRIPTION:
NATtrol™ CT.NG External Run Controls (NATCT (434)-6MC, NATNG-6MC and NATCT.NGNEG-6MC) are formulated with purified, intact bacterial particles that have been chemically modified to render them non-infectious and refrigerator stable*. Each control pack contains 6 x 1.0 mL vials of C.trachomatis NATtrolTM, N.gonorrhoeae NATtrolTM or CT.NG Negative NATtrolTM. These controls are supplied in a purified protein matrix that mimics the composition of a true clinical specimen. *NATtrol™ Patents Pending

INTENDED USE:
- NATtrol™ CT.NG External Run Controls are full process controls designed to evaluate the performance of nucleic acid tests for determination of the presence of CT.NG DNA. NATCT(434)-6MC, NATNG-6MC and NATCT.NGNEG-6MC can also be used for quality control of clinical assays and training of laboratory personnel.
- NATCT(434)-6MC, NATNG-6MC and NATCT.NGNEG-6MC contain intact organisms and should be run in a manner identical to that used for clinical specimens.

ETIOLOGIC STATUS/BIOHAZARD TESTING:
- NATtrol™ inactivation was carried out on each control. The inactivation was verified by the absence of bacterial growth in a validated growth protocol.
- The purified protein matrix was manufactured from materials that were screened and found to be negative for HIV 1&2 Ab, HBsAg, HTLV I&II Ab, HCV Ab, HIV RNA, HBV DNA and HCV RNA using FDA cleared kits at the single donor level.

Catalog #:NATNG-6MC
Catalog #:NATCT(434)-6MC
Catalog #:NATCT.NGNEG-6MC

For more information download PDF file